NCT00890578

Brief Summary

The use of tissue adhesives for the closure of surgical incisions is becoming increasingly common. Several publications exist purporting the equivalence of tissue adhesive to suture with regard to dehiscence, infection, and cosmesis. Two of the most frequently used adhesives are Histoacryl© and Dermabond©. Despite their popularity, only one study exists comparing the two. In this non-English study only small wounds in an exclusively pediatric population were studied (12). Operative time, cost, and objective measures of scar size were not examined. In the present study we aim to evaluate the relatively large surgical incisions resulting from breast reduction, mastopexy, panniculectomy, and abdominoplasty closed with either Histoacryl©, Dermabond©, or subcuticular suture. The primary aim is to investigate differences in time to wound closure. Secondary aims are to compare the three approaches with respect to cost, dehiscence, infection, scar size, and cosmesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 30, 2009

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
Last Updated

June 21, 2012

Status Verified

June 1, 2012

Enrollment Period

1.8 years

First QC Date

April 29, 2009

Last Update Submit

June 19, 2012

Conditions

Keywords

Histoacrylclosure of surgical incisions

Outcome Measures

Primary Outcomes (1)

  • Comparison of Histoacryl© to Dermabond© is lacking. Investigation of Histoacryl© in direct comparison to Dermabond© as well as to suture.

    1 year

Study Arms (2)

1-abdominal

half abdominal surgeries (20 patients out of 40)

Procedure: adhesive to suture

2-breast

half breast surgeries (20 out of 40)

Procedure: adhesive to suture

Interventions

surgical closure

Also known as: Dermabond, Histoacryl, or sutures --patients could be randomized to.
1-abdominal2-breast

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

1\) and 2): Reduction Mammoplasty or mastopexy patients: Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator. This will include patients undergoing a standard Wise pattern reduction mammoplasty (reduction and lift) or a standard Wise pattern mastopexy (lift only). See exclusion criteria below. 1\) and 2): Abdominoplasty or panniculectomy patients: Patients who present to the plastic surgery clinic and are scheduled for abdominal procedures will be recruited and consented by a clinical studies coordinator. See exclusion criteria below.

You may qualify if:

  • Age: Younger than 21
  • Gender: Females only. Given the nature of the procedures, as well as our clinical experience, we cannot anticipate recruiting enough male patients to be able to evaluate them as a subgroup. Since there may be differences in distributions of measures, to keep the groups more homogeneous we plan to recruit only females from the outset. Having either:
  • Reduction Mammoplasty or mastopexy patients:
  • Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator.

You may not qualify if:

  • Abdominoplasty or panniculectomy patients:
  • Though women of childbearing age will be allowed to participate in this study, no pregnant patients will be enrolled.
  • Patients with any factors that may have an adverse effect on wound healing:
  • previous hypertrophic scars or keloid
  • known vitamin C deficiency
  • known zinc deficiency
  • smoking
  • steroid use
  • known connective tissue disorder
  • hypoalbuminemia
  • any factor not listed that the attending consultant seeing the patient feels would adversely effect wound healing.
  • Patients who have a known sensitivity to adhesives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Florida

Jacksonville, Florida, 32224, United States

Location

MeSH Terms

Conditions

Surgical Wound

Interventions

octyl 2-cyanoacrylateEnbucrilate

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

CyanoacrylatesAcrylatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsNitrilesPolymersMacromolecular SubstancesBiomedical and Dental MaterialsTissue AdhesivesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Galen Perdikis, M.D.

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 29, 2009

First Posted

April 30, 2009

Study Start

April 1, 2009

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

June 21, 2012

Record last verified: 2012-06

Locations